Einstein Eecp - 19111 Philadelphia, PA

Business Name: Einstein Eecp
Categorized In: Doctors
Address: 700 Cottman Avenue, Philadelphia, PA 19111
Phone Number: (215) 342-2100
Contact Person: Domonique Pratt, Office Manager
Website Address: bravermancenters.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $1.000.000 to $2.499.999
Share This Business:
Similar Businesses: Murali Vijayalaksh MD - Philadelphia, PA 19111
Olszanski Anthony J MD - Philadelphia, PA 19111
Partridge Brett MD - Philadelphia, PA 19111
Brislin Brian T MD - Philadelphia, PA 19111
David M Fiss MD - Philadelphia, PA 19111
Shaw Christiana MD - Philadelphia, PA 19111
Zook Matthew B MD - Philadelphia, PA 19111
Sobczak Mark L MD - Philadelphia, PA 19111
Boorjian Stephen A MD - Philadelphia, PA 19111
Shanbhag Satish P MD - Philadelphia, PA 19111
Li Linna MD - Philadelphia, PA 19111
Patel Sameer A MD - Philadelphia, PA 19111
Telivala Bijoy P MD - Philadelphia, PA 19111
Young Robert C MD - Philadelphia, PA 19111
Chen Emmie MD - Philadelphia, PA 19111
Dzurinko David J DO - Philadelphia, PA 19111
Kailasam Mala MD - Philadelphia, PA 19111
Rao Poornima B MD - Philadelphia, PA 19111
Mackenzie Amy R MD - Philadelphia, PA 19111
Haugh Deanna L MD - Philadelphia, PA 19111

Einstein Eecp provides professional Doctors from its single location at the coordinates 40.063549,-75.087457.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $1.000.000 to $2.499.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 700 Cottman Avenue, Philadelphia, Pennsylvania 19111 or contacted through representative Domonique Pratt, Office Manager at (215) 342-2100.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Einstein Eecp through its company website at bravermancenters.com. Engage with this business on its social media platforms through on Twitter and on Facebook.